CSL Seqirus Holly Springs Fill Finish Expansion Completion

Описание к видео CSL Seqirus Holly Springs Fill Finish Expansion Completion

CSL Seqirus completed a $156million expansion to its Holly Springs manufacturing facility, optimizing global manufacturing capabilities for seasonal and pandemic influenza vaccines. The expansion supports the formulation and fill-finish of its cell-based influenza vaccines in pre-filled syringes for global communities.

Learn more at: https://www.seqirus.com/news/seqirus-....

Комментарии

Информация по комментариям в разработке